Archive · 3 Oct 2026
PB Fintech Shares Fall 48% as Proposed Insurance Rules Raise Concerns
PB Fintech owns Policybazaar and Paisabazaar.
Its shares fell sharply over six trading sessions, losing about 48%.
The fall followed proposed changes to rules about how insurance companies pay distributors.
Investors worry that lower commissions could mean less money for parts of PB Fintech’s insurance business.
Analysts have lowered their price targets, though some still rate the stock positively or neutrally.
The rules are proposals, and the consultation paper may change after feedback in October.
The changes are expected to take effect from FY28 if implemented.
Mutual funds that owned the shares have a large paper loss based on the latest share price.
PB Fintech may need to adjust costs or find other ways to earn from insurance.
PB Fintech shares fell about 48% over six consecutive sessions, closing at ₹980 on October 1 after touching an intraday low of ₹965.
The stock returned to around its November 2021 IPO price and was more than 50% below its December 52-week high of ₹1,963.
Investors and analysts are concerned that proposed IRDAI commission and distribution-rule changes could reduce earnings from general and health insurance, including the POSP business.
Bernstein cut its target price 53% to ₹1,085 but kept an Outperform rating; Jefferies cut its target to ₹1,540 and retained Buy.
At the end of the June quarter, mutual funds held 28.32% of PB Fintech; the reported decline implied a notional loss of about ₹11,726 crore for those funds.
- Who
- PB Fintech, the parent company of Policybazaar and Paisabazaar; investors and brokerages are also affected.
- What
- Its shares fell about 48% in six sessions amid concerns about proposed insurance commission and distribution rules.
- When
- The latest reported close was October 1; the decline occurred over six consecutive sessions.
- Where
- PB Fintech shares traded at ₹980 on October 1, after reaching an intraday low of ₹965.
- Why
- Investors fear proposed lower commissions and other distribution changes could reduce earnings from PB Fintech’s insurance businesses.
Earnings and valuation concerns
Potential resilience and uncertainty
Effect of proposed commission changes
Earnings and valuation concerns
Bernstein said reduced general-insurance take rates could be insufficient to cover current costs. Morgan Stanley estimated a 60–70% decline in health-business NPV under the proposed framework, and Jefferies cited a possible 33–40% of original non-life NPV.
Potential resilience and uncertainty
Jefferies expects life-insurance NPV to remain broadly similar, supported by renewal commissions in term insurance. The regulatory proposals are not final and may be revised after feedback.
PB Fintech’s ability to adapt
Earnings and valuation concerns
Bernstein described the next 18 months as critical and said the POSP business could scale down; it excluded uncertain mitigation benefits from its forecasts.
Potential resilience and uncertainty
Brokerages noted possible responses or opportunities, including cost controls, alternative business models, manufacturing, reinsurance broking, new products, and potential MGA regulation.
Stock outlook
Earnings and valuation concerns
Brokerages cut targets substantially, citing regulatory uncertainty, lower take-rates, and valuation risks.
Potential resilience and uncertainty
Despite cuts, Bernstein retained Outperform, Jefferies retained Buy, HSBC retained Hold, and Motilal Oswal retained Neutral; some reports said FY27 and FY28 earnings estimates were largely unchanged.
- October 1 closing price
- ₹980, after an 8% fall that day
- Six-session decline
- About 48%
- Intraday low
- ₹965 on October 1
- December 52-week high
- ₹1,963
- Mutual-fund ownership
- 37 funds held a combined 28.32% stake at the end of the June quarter
- Estimated mutual-fund notional loss
- About ₹11,726 crore, based on the October 1 closing price
- Proposed rule timing
- Expected from FY28 if implemented; the consultation paper may be revised after October feedback
- Selected brokerage targets
- Bernstein: ₹1,085; Jefferies: ₹1,540; HSBC and Motilal Oswal: ₹1,150
